-
Full Article (HTML) (122) -
Full Article (PDF) (50) -
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8622)
All Articles published online
|
Publishing Process of This Article
|
Jan 7, 2016 (publication date) through Aug 9, 2022
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Han K, Kim JH, Ko GY, Gwon DI, Sung KB. Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review. World J Gastroenterol 2016; 22(1): 407-416 [PMID: 26755886 DOI: 10.3748/wjg.v22.i1.407] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i1/407.htm |
| Number | Citing Articles |
| 1 |
Jun An, Zhigang Zhang, Zhiyong Liu, Ruizhi Wang, Dayang Hui, Yi Jin. Overexpression of Cullin7 is associated with hepatocellular carcinoma progression and pathogenesis. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3839-7
|
| 2 |
Zi-Wen Tao, Bao-Quan Cheng, Tao Zhou, Yan-Jing Gao. Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review. Hepatobiliary & Pancreatic Diseases International 2022; 21(2): 134 doi: 10.1016/j.hbpd.2021.12.004
|
| 3 |
Jack P. Silva, Nicholas G. Berger, Susan Tsai, Kathleen K. Christians, Callisia N. Clarke, Harveshp Mogal, Sarah White, William Rilling, T. Clark Gamblin. Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis. HPB 2017; 19(8): 659 doi: 10.1016/j.hpb.2017.04.016
|
| 4 |
Yang Liu, Hongbo Zou, Qichao Xie, Lan Zou, Rui Kong, Bijing Mao. Ribonucleic acid-binding protein CPSF6 promotes glycolysis and suppresses apoptosis in hepatocellular carcinoma cells by inhibiting the BTG2 expression. BioMedical Engineering OnLine 2021; 20(1) doi: 10.1186/s12938-021-00903-6
|
| 5 |
Jing Chen, Di Wu, Yue Zhang, Yong Yang, Yunfei Duan, Yong An. LncRNA DCST1-AS1 functions as a competing endogenous RNA to regulate FAIM2 expression by sponging miR-1254 in hepatocellular carcinoma. Clinical Science 2019; 133(2): 367 doi: 10.1042/CS20180814
|
| 6 |
Bo Liu, Tianyu Xiong, Jian Lu, Shengwei Li, Xiangzhi Bai, Fugen Zhou, Qiuwen Wu.
Technical note: A fast and accurate analytical dose calculation algorithm for
125
I seed‐loaded stent applications
. Medical Physics 2021; 48(11): 7493 doi: 10.1002/mp.15207
|
| 7 |
Yue Yang, Pingya He, Ning Li. The Antitumor Potential of Extract of the Oak Bracket Medicinal Mushroom Inonotus baumii in SMMC-7721 Tumor Cells. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/1242784
|
| 8 |
In-Jung Kim, Sung Hwan Yoo, Jung Il Lee, Kwan Sik Lee, Hyun Woong Lee, Jin Hong Lim. Long-term survival after CCRT and HAIC followed by ALPPS for hepatocellular carcinoma with portal vein invasion: a case report. Journal of Liver Cancer 2022; 22(1): 84 doi: 10.17998/jlc.2022.03.07
|
| 9 |
Seongmoon Jung, Sui Shen, Sung-Joon Ye. Dose perturbation and inhomogeneity of multi-arrays of 125I seed-loaded stent for treatment of portal vein tumor thrombosis. Physica Medica 2019; 66: 1 doi: 10.1016/j.ejmp.2019.09.077
|
| 10 |
Yang Gao, Peng‐Xiang Wang, Jian‐Wen Cheng, Yun‐Fan Sun, Bo Hu, Wei Guo, Kai‐Qian Zhou, Yue Yin, Yuan‐Cheng Li, Jian Wang, Jun‐Feng Huang, Shuang‐Jian Qiu, Jian Zhou, Jia Fan, Xin‐Rong Yang. Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score‐matched survival analysis. Cancer Medicine 2019; 8(16): 6933 doi: 10.1002/cam4.2556
|
| 11 |
Tao Sun, Lei Chen, Xuefeng Kan, Yanqiao Ren, Yanyan Cao, Weihua Zhang, Haohao Lu, Chuansheng Zheng, San Lin You. A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/1255133
|
| 12 |
Maria Grazia Lucà, Roberto Nani, Melanie Schranz, Massimo De Giorgio, Claudia Iegri, Roberto Agazzi, Francesco Sala, Giorgio Virotta, Donatella Sarti, Grazia Conte, Domenico Pinelli, Carlo Nicora, Michele Colledan, Sandro Sironi, Stefano Fagiuoli. Treatment of hepatocellular carcinoma: a cost analysis of yttrium-90 transarterial radioembolization versus sorafenib. Future Oncology 2018; 14(8): 727 doi: 10.2217/fon-2017-0566
|
| 13 |
Xinhua Zou, Wenzhe Fan, Miao Xue, Jiaping Li. Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) Progression. Cancer Management and Research 2021; : 4013 doi: 10.2147/CMAR.S304591
|
| 14 |
Jianchu Wang, Qianli Tang, Libai Lu, Zongjiang Luo, Wenchuan Li, Yuan Lu, Jian Pu. LncRNA OIP5-AS1 interacts with miR-363-3p to contribute to hepatocellular carcinoma progression through up-regulation of SOX4. Gene Therapy 2020; 27(10-11): 495 doi: 10.1038/s41434-020-0123-2
|
| 15 |
Jun An, Zhiyong Liu, Qiong Liang, Yuhang Pan, Haifeng Li, Ruizhi Wang, Yi Jin. Overexpression of Rabl3 and Cullin7 is associated with pathogenesis and poor prognosis in hepatocellular carcinoma. Human Pathology 2017; 67: 146 doi: 10.1016/j.humpath.2017.07.008
|
| 16 |
Jin Hyoung Kim, Ju Hyun Shim, Hyun‐Ki Yoon, Heung‐Kyu Ko, Jong Woo Kim, Dong Il Gwon. Chemoembolization related to good survival for selected patients with hepatocellular carcinoma invading segmental portal vein. Liver International 2018; 38(9): 1646 doi: 10.1111/liv.13719
|
| 17 |
Miao Chen, Duo Wang, Yuan Zhao, Dan‑Mei Lu, Hong‑Xue Li, Jun‑Jie Liu, Hang Li. Preoperative color Doppler ultrasonography predicts early recurrence in AFP‑positive hepatocellular carcinoma. Oncology Letters 2019; doi: 10.3892/ol.2019.10825
|
| 18 |
Nokjung Kim, Myung-Won You. Hepatocellular carcinoma and macrovascular tumor thrombosis: treatment outcomes and prognostic factors for survival. Japanese Journal of Radiology 2019; 37(11): 781 doi: 10.1007/s11604-019-00868-6
|
| 19 |
Shunnan Yao, Jianpin Ye, Mengqi Yin, Rui Yu. DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo. Cancer Letters 2020; 483: 87 doi: 10.1016/j.canlet.2020.04.003
|
| 20 |
Junqing Lin, Han Jiang, Weizhu Yang, Na Jiang, Qubin Zheng, Ning Huang, Xiaolong Wang, Ang Li, Jingyao Huang. Predictive factors of benefit from iodine-125 brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis. Brachytherapy 2019; 18(2): 233 doi: 10.1016/j.brachy.2018.10.002
|
| 21 |
Leandro Cardarelli-Leite, John Chung, Darren Klass, Vladimir Marquez, Frank Chou, Stephen Ho, Henry Walton, Howard Lim, Peter Tae Wan Kim, Anastasia Hadjivassiliou, David M. Liu. Ablative Transarterial Radioembolization Improves Survival in Patients with HCC and Portal Vein Tumor Thrombus. CardioVascular and Interventional Radiology 2020; 43(3): 411 doi: 10.1007/s00270-019-02404-5
|
| 22 |
Yi-Fan Wu, Tao Wang, Zhen-Dong Yue, Hong-Wei Zhao, Lei Wang, Zhen-Hua Fan, Fu-Liang He, Fu-Quan Liu. Stents combined with iodine-125 implantation to treat main portal vein tumor thrombus. World Journal of Gastrointestinal Oncology 2018; 10(12): 496-504 doi: 10.4251/wjgo.v10.i12.496
|
| 23 |
Sumit Siddharth, Panjamurthy Kuppusamy, Qitong Wu, Arumugam Nagalingam, Neeraj K. Saxena, Dipali Sharma. Metformin Enhances the Anti-Cancer Efficacy of Sorafenib via Suppressing MAPK/ERK/Stat3 Axis in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2022; 23(15): 8083 doi: 10.3390/ijms23158083
|
| 24 |
Dong Hyun Kim, Eunae Cho, Sung Bum Cho, Sung Kyu Choi, Sunmin Kim, Jieun Yu, Young-Il Koh, Da Woon Sim, Chung Hwan Jun. Complete response of hepatocellular carcinoma with right atrium and pulmonary metastases treated by combined treatments (a possible treatment effect of natural killer cell). Medicine 2018; 97(42): e12866 doi: 10.1097/MD.0000000000012866
|
| 25 |
Pyeong Hwa Kim, Sang Hyun Choi, Jin Hyoung Kim, Seong Ho Park. Comparison of Radioembolization and Sorafenib for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Meta-Analysis of Safety and Efficacy. Korean Journal of Radiology 2019; 20(3): 385 doi: 10.3348/kjr.2018.0496
|
| 26 |
Sumit Siddharth, Nethaji Muniraj, Neeraj Saxena, Dipali Sharma. Concomitant Inhibition of Cytoprotective Autophagy Augments the Efficacy of Withaferin A in Hepatocellular Carcinoma. Cancers 2019; 11(4): 453 doi: 10.3390/cancers11040453
|
| 27 |
Zhiwen Yang, Ruhai Zou, Yun Zheng, Jiliang Qiu, Jingxian Shen, Yadi Liao, Yuanping Zhang, Chenwei Wang, Yongjin Wang, Yichuan Yuan, Kai Li, Dinglan Zuo, Wei He, Wenwu Liu, Binkui Li, Yunfei Yuan. Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation. European Radiology 2019; 29(11): 5752 doi: 10.1007/s00330-019-06157-0
|
| 28 |
Shuangxi Li, Lei Li, Baohua Li, Wenhui Wang. Safety and efficacy of endovascular implantation of a portal vein stent combined with iodine-125 seed-strips followed by transcatheter arterial chemoembolization with sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis. The British Journal of Radiology 2020; 93(1112): 20190279 doi: 10.1259/bjr.20190279
|
| 29 |
Xiao-Chun Meng, Bing-Hui Chen, Jing-Jun Huang, Wen-Sou Huang, Ming-Yue Cai, Jing-Wen Zhou, Yong-Jian Guo, Kang-Shun Zhu. Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib. World Journal of Gastroenterology 2018; 24(4): 484-493 doi: 10.3748/wjg.v24.i4.484
|
| 30 |
Li-Hong Yao, Liang Su, Lu Liu, Hai-Tao Sun, Jun-Jie Wang. Stenting of the Portal Vein Combined with Different Numbers of Iodine-125 Seed Strands. Chinese Medical Journal 2017; 130(18): 2183 doi: 10.4103/0366-6999.213974
|
| 31 |
Ghada H. Mansour, Mohammed A. El-Magd, Dalia H. Mahfouz, Ismail A. Abdelhamid, Magda F. Mohamed, Nada S. Ibrahim, Abdel Hady A. Abdel Wahab, Emad M. Elzayat. Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cells. Bioorganic Chemistry 2021; 116: 105329 doi: 10.1016/j.bioorg.2021.105329
|
| 32 |
Lucia Cerrito, Brigida Eleonora Annicchiarico, Roberto Iezzi, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani. Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers. World Journal of Gastroenterology 2019; 25(31): 4360-4382 doi: 10.3748/wjg.v25.i31.4360
|
| 33 |
Su Ho Kim, Jung Suk Oh, Ho Jong Chun, Byung Gil Choi, Hae Giu Lee. Dual-Port versus Mono-Port Implantation for Intra-Arterial Chemoinfusion Therapy for Treatment of Hepatocellular Carcinoma in Patients with Anatomic Hepatic Artery Variation. Journal of Vascular and Interventional Radiology 2019; 30(1): 23 doi: 10.1016/j.jvir.2018.06.006
|
| 34 |
Jenny Que, Hung-Chang Wu, Chia-Hui Lin, Chung-I Huang, Li-Ching Li, Chung-Han Ho. Comparison of stereotactic body radiation therapy with and without sorafenib as treatment for hepatocellular carcinoma with portal vein tumor thrombosis. Medicine 2020; 99(13): e19660 doi: 10.1097/MD.0000000000019660
|
| 35 |
Tan Tan, Yudong Xiao, Shunke Zhou, Cong Ma, Zishu Zhang. Y-configuration stent combined with iodine-125 seeds strand for the treatment of hepatocellular carcinoma with tumor thrombosis in portal vein branches. Medicine 2017; 96(46): e8660 doi: 10.1097/MD.0000000000008660
|
| 36 |
Wen Peng Zhao, Honglu Li, Jiang Guo, Liang Cai, Youjia Duan, Xiaopu Hou, Hongliu Du, Xihong Shao, Zhenying Diao, Changqing Li. Hepatocellular carcinoma with type II–III portal vein tumour thrombosis: treatment using transarterial chemoembolisation and microwave ablation. The British Journal of Radiology 2021; 94(1117): 20200415 doi: 10.1259/bjr.20200415
|
| 37 |
Xiaojie Li, Zhimin Ye, Sheng Lin, Haowen Pang. Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogram. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08469-1
|
| 38 |
Teng Li, Yun Liu, Yanming Sun. Long non-coding RNA AB209630 suppresses cell proliferation and metastasis in human hepatocellular carcinoma. Experimental and Therapeutic Medicine 2017; 14(4): 3419 doi: 10.3892/etm.2017.4927
|
| 39 |
Qifan He, Jian Yang, Yonghai Jin. Immune infiltration and clinical significance analyses of the coagulation-related genes in hepatocellular carcinoma. Briefings in Bioinformatics 2022; 23(4) doi: 10.1093/bib/bbac291
|
| 40 |
Chung Hwan Jun, Jae Hyun Yoon, Eunae Cho, Sang Soo Shin, Sung Bum Cho, Hee Joon Kim, Chang Hwan Park, Hyun Soon Kim, Sung Kyu Choi, Jong Sun Rew. Barcelona clinic liver cancer-stage C hepatocellular carcinoma. Medicine 2017; 96(17): e6745 doi: 10.1097/MD.0000000000006745
|
| 41 |
Chun-San Tai, Yan-Ren Lin, Tsung-Han Teng, Ping-Yi Lin, Siang-Jyun Tu, Chih-Hung Chou, Ya-Rong Huang, Wei-Chih Huang, Shun-Long Weng, Hsien-Da Huang, Yao-Li Chen, Wen Liang Chen, William B. Coleman. Haptoglobin expression correlates with tumor differentiation and five-year overall survival rate in hepatocellular carcinoma. PLOS ONE 2017; 12(2): e0171269 doi: 10.1371/journal.pone.0171269
|
| 42 |
Yuhang Pan, Zhiyong Liu, Zhiying Feng, Dayang Hui, Xiangqi Huang, Dayue Tong, Yi Jin. The overexpression of Rabl3 is associated with pathogenesis and clinicopathologic variables in hepatocellular carcinoma. Tumor Biology 2017; 39(4): 101042831769623 doi: 10.1177/1010428317696230
|